Trading Signals
Iovance (IOVA) Stock On The Rise: Early Session Indicates Positive Trajectory
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is experiencing a notable surge in its stock value, with a 6.34% increase to $16.77 during the morning session. This uptrend follows a previous rally where IOVA stock saw a significant 31.09% rise, closing at $15.77. The catalyst behind this positive market response is the recent approval by the U.S. Food and Drug Administration (FDA) of AMTAGVI (lifileucel) suspension for intravenous infusion. AMTAGVI represents a groundbreaking advancement as the first FDA-approved individualized T cell therapy for solid tumor cancer. It harnesses patient-specific T cells, known as TIL cells, which are integral to the body’s natural
